Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

The protective effect of blocking angiotensin in both type I and type II diabetics with nephropathy

Journal of Human Hypertension volume 15, pages 837–839 (2001)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ruggenenti P et alChronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352patients with differing patterns of renal injury Am J Kidney Dis 2000 35 1155–1165

    Article  CAS  Google Scholar 

  2. Ravid M et alLong-term stabilising effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabeticpatients Ann Intern Med 1993 118 577–581

    Article  CAS  Google Scholar 

  3. Gansevoort RT, de Zeeuw D, de Jong PE Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 1994 45 861–867

    Article  CAS  Google Scholar 

  4. Maschio G et alEffect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal inefficiency N Engl J Med 1996 34 939–945

    Article  Google Scholar 

  5. Lewis EJ et alThe effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy N Engl J Med 1993 329 1456–1462

    Article  CAS  Google Scholar 

  6. Price DA et alThe paradox of the low-renin state in diabetic nephropathy J Am Soc Nephrol 1999 10 238–291

    Google Scholar 

  7. Lewis EJ, Hunsicker LG, Clarke WR Reno protective effect of the angiotensin-receptor antagonist irbesartan inpatients with nephropathy due to type 2 diabetes N Engl J Med 2001 345 851

    Article  CAS  Google Scholar 

  8. Parving HH et alEffect of irbesartan on the development of diabetic nephropathy inpatients with type 2 diabetes N Engl J Med 2001 345 870–878

    Article  CAS  Google Scholar 

  9. Brenner BM et alEffects of losartan on renal and cardiovascular outcomes inpatients with type 2 diabetes and nephropathy N Engl J Med 2001 345 861–869

    Article  CAS  Google Scholar 

  10. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators Effects of ramipril on cardiovascular and micro-vascular outcomes in people with diabetes mellitus, results of the HOPE study and the MICRO-HOPE sub-study Lancet 2000 355 235–239

    Google Scholar 

  11. UK Prospective Diabetes Study (UKPDS) group Efficacy of atenolol and captopril in reducing risk of macro-vascular and micro-vascular complications in type II diabetes, UKPDS 39 BMJ 1998 317 713–720

    Article  Google Scholar 

  12. Pitt B et alThe effect of losartan compared with captopril on mortality inpatients with symptomatic heart failure: randomised trial – the losartan heart failure survival study ELITE II Lancet 2000 355 1582–1587

    Article  CAS  Google Scholar 

  13. African American Study of Kidney Disease and Hypertension (AASK) Study Group The effect of Ramipril vs Amlodipine on renal outcomes in hypertensive nephrosclerosis; a randomised controlled trial JAMA 2001 285 2719–2728

    Article  Google Scholar 

  14. Neal B, MacMahon S, Chapman N The effects of ACE inhibitors, calcium antagonists and other blood pressure lowering drugs: results of prospective designed overviews of randomised trials Lancet 2000 356 1955–1964

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Department of Medicine, City Hospital, Birmingham, B18 7QH, UK

    DG Beevers & GYH Lip

Authors
  1. DG Beevers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. GYH Lip
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beevers, D., Lip, G. The protective effect of blocking angiotensin in both type I and type II diabetics with nephropathy. J Hum Hypertens 15, 837–839 (2001). https://doi.org/10.1038/sj.jhh.1001309

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001309

Keywords

This article is cited by

Search

Advanced search

Quick links